Latest news
Alteogen Announces Exclusive License Agreement with a Global Pharmaceutical Company for the Development and Commercialization of a Hybrozyme™-Enabled Subcutaneous Biologic Product - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:00:00 GMTKaléo Announces License Agreement with Amgen for Auto-Injector Technology - GlobeNewswireGlobeNewswire · Mon, 03 Aug 2026 12:00:00 GMT